Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979758855> ?p ?o ?g. }
- W2979758855 endingPage "576" @default.
- W2979758855 startingPage "568" @default.
- W2979758855 abstract "Purpose: Chalcones are precursors of flavonoids with a wide range of pharmacological activities. This study evaluates the anti-inflammatory effect of indole based chalcone derivative (2E)-3-(4-bromophenyl)-1-(1H-indol-3-yl) prop-2-en-1-one (IC9) on lipopolysaccharide (LPS) activated murine macrophages RAW264.7 cells and carrageenan-induced acute model in rats.Materials and methods: LPS-treated RAW264.7 cell lines and carrageenan-induced animal model were employed to evaluate the anti-inflammatory activity of IC9. The cell cytotoxicity studies were carried out by MTT assay. Reactive oxygen species (ROS) production and other inflammatory markers such as prostaglandin E2 (PGE2), nitric oxide (NO) as well as cyclooxygenase-2 (COX-2) activity were determined using ELISA. The RT-PCR was performed to determine mRNA expressions in the case of inducible nitric oxide synthase (iNOS), COX-2, Toll-like receptor-4 (TLR-4) and also nuclear translocation of NF-κB activity.Results: LPS-activated RAW264.7 cells showed an increased level of ROS generation and other inflammatory markers such as PGE2, NO level and COX-2 activity. Expression of iNOS, COX- 2 and TLR-4 mRNA expression were also up-regulated along with nuclear translocation of NF-κB. On IC9 supplementation, all the above parameters of LPS-activated cells were found to be reversed, resembling the control group. Moreover, IC9 significantly inhibited paw swelling and exhibited maximum inhibition of 78.45% at low dose of 7.5 mg/kg.bwt.Conclusions: The targeting anti-inflammatory efficacy and profound NF-κB sensitive transcriptional regulatory mechanism of IC9 accounts for its effective anti-inflammatory action." @default.
- W2979758855 created "2019-10-18" @default.
- W2979758855 creator A5023941392 @default.
- W2979758855 creator A5043214503 @default.
- W2979758855 creator A5052219907 @default.
- W2979758855 creator A5053170077 @default.
- W2979758855 creator A5072466325 @default.
- W2979758855 creator A5086242816 @default.
- W2979758855 date "2019-10-08" @default.
- W2979758855 modified "2023-09-25" @default.
- W2979758855 title "Anti-inflammatory effect of synthesized indole-based chalcone (2E)-3-(4-bromophenyl)-1-(1<i>H</i>-indol-3-yl) prop-2-en-1-one: an <i>in vitro</i> and <i>in vivo</i> studies" @default.
- W2979758855 cites W1548341825 @default.
- W2979758855 cites W1965301424 @default.
- W2979758855 cites W1976382352 @default.
- W2979758855 cites W1981819970 @default.
- W2979758855 cites W1984368960 @default.
- W2979758855 cites W1987781980 @default.
- W2979758855 cites W1990893520 @default.
- W2979758855 cites W1993123663 @default.
- W2979758855 cites W2005435407 @default.
- W2979758855 cites W2007356331 @default.
- W2979758855 cites W2032620358 @default.
- W2979758855 cites W2039988997 @default.
- W2979758855 cites W2044203934 @default.
- W2979758855 cites W2045471869 @default.
- W2979758855 cites W2045789207 @default.
- W2979758855 cites W2060630213 @default.
- W2979758855 cites W2063825413 @default.
- W2979758855 cites W2072291431 @default.
- W2979758855 cites W2080296240 @default.
- W2979758855 cites W2091326645 @default.
- W2979758855 cites W2101363646 @default.
- W2979758855 cites W2114918609 @default.
- W2979758855 cites W2116766330 @default.
- W2979758855 cites W2129319296 @default.
- W2979758855 cites W2144192610 @default.
- W2979758855 cites W2147921405 @default.
- W2979758855 cites W2149200346 @default.
- W2979758855 cites W2149512337 @default.
- W2979758855 cites W2152309068 @default.
- W2979758855 cites W2166781237 @default.
- W2979758855 cites W2461367596 @default.
- W2979758855 doi "https://doi.org/10.1080/08923973.2019.1672177" @default.
- W2979758855 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31594421" @default.
- W2979758855 hasPublicationYear "2019" @default.
- W2979758855 type Work @default.
- W2979758855 sameAs 2979758855 @default.
- W2979758855 citedByCount "8" @default.
- W2979758855 countsByYear W29797588552020 @default.
- W2979758855 countsByYear W29797588552021 @default.
- W2979758855 countsByYear W29797588552022 @default.
- W2979758855 countsByYear W29797588552023 @default.
- W2979758855 crossrefType "journal-article" @default.
- W2979758855 hasAuthorship W2979758855A5023941392 @default.
- W2979758855 hasAuthorship W2979758855A5043214503 @default.
- W2979758855 hasAuthorship W2979758855A5052219907 @default.
- W2979758855 hasAuthorship W2979758855A5053170077 @default.
- W2979758855 hasAuthorship W2979758855A5072466325 @default.
- W2979758855 hasAuthorship W2979758855A5086242816 @default.
- W2979758855 hasConcept C109316439 @default.
- W2979758855 hasConcept C134018914 @default.
- W2979758855 hasConcept C178790620 @default.
- W2979758855 hasConcept C185592680 @default.
- W2979758855 hasConcept C202751555 @default.
- W2979758855 hasConcept C203014093 @default.
- W2979758855 hasConcept C2777622882 @default.
- W2979758855 hasConcept C2777730290 @default.
- W2979758855 hasConcept C2777956040 @default.
- W2979758855 hasConcept C2778754761 @default.
- W2979758855 hasConcept C2780764945 @default.
- W2979758855 hasConcept C2780783641 @default.
- W2979758855 hasConcept C48349386 @default.
- W2979758855 hasConcept C519581460 @default.
- W2979758855 hasConcept C55493867 @default.
- W2979758855 hasConcept C62478195 @default.
- W2979758855 hasConcept C71240020 @default.
- W2979758855 hasConcept C86803240 @default.
- W2979758855 hasConcept C98274493 @default.
- W2979758855 hasConceptScore W2979758855C109316439 @default.
- W2979758855 hasConceptScore W2979758855C134018914 @default.
- W2979758855 hasConceptScore W2979758855C178790620 @default.
- W2979758855 hasConceptScore W2979758855C185592680 @default.
- W2979758855 hasConceptScore W2979758855C202751555 @default.
- W2979758855 hasConceptScore W2979758855C203014093 @default.
- W2979758855 hasConceptScore W2979758855C2777622882 @default.
- W2979758855 hasConceptScore W2979758855C2777730290 @default.
- W2979758855 hasConceptScore W2979758855C2777956040 @default.
- W2979758855 hasConceptScore W2979758855C2778754761 @default.
- W2979758855 hasConceptScore W2979758855C2780764945 @default.
- W2979758855 hasConceptScore W2979758855C2780783641 @default.
- W2979758855 hasConceptScore W2979758855C48349386 @default.
- W2979758855 hasConceptScore W2979758855C519581460 @default.
- W2979758855 hasConceptScore W2979758855C55493867 @default.
- W2979758855 hasConceptScore W2979758855C62478195 @default.
- W2979758855 hasConceptScore W2979758855C71240020 @default.
- W2979758855 hasConceptScore W2979758855C86803240 @default.
- W2979758855 hasConceptScore W2979758855C98274493 @default.
- W2979758855 hasIssue "6" @default.